FindTrial
Sign In

The software of the new device which tests the side vision of the eye will be evaluated.

Properties of perimetric threshold estimates from Full Threshold, Elisar ZEST, and Elisar Fast strategies.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/08/020861
Enrollment
150
Registered
2019-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H409- Unspecified glaucoma

Interventions

None listed

Sponsors

Dr Amar Agarwal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The best-corrected visual acuity should be 6/6 or better. 2. Spherical equivalent of the refraction should be less than or equal to 5D

Exclusion criteria

Exclusion criteria: 1. Fixation losses, false-positive and false-negative greater than 20% will be excluded from the study. 2. Patients using a miotic drug will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
This will evaluate the Full threshold, Elisar Zest, Elisar fast and Elisar Screening. This will give a knowledge on how accurate the above strategies are.Timepoint: 90 days—

Secondary

MeasureTime frame
Repeatability of each strategy will also be calculated.Timepoint: 90 days—

Countries

India

Contacts

Public ContactMaheswari Srinivasan

Dr Agarwalâ??s eye hospitals

maheswari.srinivasan@dragarwal.com09841661134

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026